Roche Holding AG
ROG.SW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$269.61B
Close$
$565.23
75.4% upside
Current Fair Value
75.4% upsideUndervalued by 75.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $269.61 Billion |
|---|---|
| Enterprise Value | $295.82 Billion |
| Annual dividend | $9.80 |
| Dividend yield | 2.51% |
| Earnings per Share | $16.18 |
| Beta | 0.21 |
| Outstanding Shares | 796,000,000 |
Return
| Return on Equity | 66.85% |
|---|---|
| Return on Assets | 22.26% |
| Return on Invested Capital | 42.92% |
Valuation & Multiples
| P/E Ratio | 25.41 |
|---|---|
| PEG | -325.98 |
| Price to Sales | 2.09 |
| Price to Book Ratio | 7.16 |
| Enterprise Value to Revenue | 2.4 |
| Enterprise Value to EBIT | 9.99 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.97 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Roche Holding AG
103,249 employees
CEO: Severin Schwan
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ...